News

Frederik van der Kooi's Strategic $226,100 Investment in Criteo

Frederik van der Kooi's Strategic $226,100 Investment in Criteo

Frederik van der Kooi's Significant Purchase of Criteo Shares

Recent disclosures from the SEC have highlighted a noteworthy insider transaction by Frederik van der Kooi, a Board Member at Criteo (NASDAQ: CRTO). On November 4, van der Kooi acquired a remarkable total of 10,000 shares of Criteo, estimated at a value of $226,100.

The Current Market Performance of Criteo

In the latest trading session, Criteo's stock exhibited a modest increase, rising by 0.82% to secure a price of $22.25. Understanding insider trading activities becomes pertinent for investors, as such movements may signal anticipated fluctuations in stock value.

Unpacking Criteo’s Operations

Criteo SA is a prominent player in the digital advertising sector, leveraging innovative technology to facilitate marketing campaigns across multiple channels. Its dynamic approach allows retailers to adapt their advertising strategies in real time based on performance analytics. Criteo operates under two primary segments: Retail Media and Performance Media, serving to bolster its clients' advertising efficacy.

A Look at Criteo's Financials

Revenue Trends: In their latest financial reporting, which concluded on September 30, 2025, Criteo reported a revenue growth rate of approximately 2.35%. While this growth illustrates a positive trend, it remains below the average growth rates seen in its industry peers.

  • Profitability Analysis:
    • Gross Margin: Criteo currently operates with a gross margin of 54.61%, which raises concerns about its competitiveness in maintaining solid profits in comparison to its industry counterparts.

    • Earnings per Share (EPS): On a brighter note, Criteo is performing well above industry standards with an EPS of 0.72, signifying strong earnings.

Debt Management: The company's debt-to-equity ratio is commendably low at 0.1, indicating a cautious financial strategy that relies less on external debt.

Valuation Metrics of Criteo

  • Price to Earnings (P/E) Ratio: Criteo's P/E ratio stands at 7.45, indicating that the stock might be undervalued compared to its rivals.

  • Price to Sales (P/S) Ratio: The P/S ratio is at 0.63, further suggesting that the stock shows promise for undervaluation as an investment opportunity.

  • EV/EBITDA Ratio: Criteo registers an EV/EBITDA ratio of 2.85, below industry standards, further hinting at potential undervaluation which could appeal to value-centric investors.

Market Capitalization Context: Currently, Criteo’s market capitalization lags behind industry averages, potentially limiting its size and growth prospects impacted by market expectations and operational capabilities.

Insights on Insider Transactions

Investor consideration of insider purchases is essential, yet these actions should be analyzed alongside a broader set of investment indicators. By definition, an insider includes any executive, director, or stakeholder owning over ten percent of a company's equity, and these individuals are obliged to report transactions via Form 4 filings within two days.

When an insider chooses to purchase shares, it often reflects optimism about the company's future performance. However, it’s important to note that sales from insiders do not always suggest negative outlooks, as many factors can influence a decision to sell.

Understanding Transaction Codes

In stock transactions, various codes indicate the nature of the actions taken. For instance, a recording of P signifies a share purchase, while S indicates a sale. Codes that reflect options conversion or grants can further illustrate the dynamics of corporate share distribution.

Frequently Asked Questions

What was Frederik van der Kooi's transaction regarding Criteo?

Frederik van der Kooi purchased 10,000 shares of Criteo, valued at $226,100.

How has Criteo's stock performed recently?

Criteo's shares increased by 0.82%, reaching a price of $22.25 in the latest trading session.

What does Criteo do?

Criteo specializes in digital advertising, providing technology for multichannel marketing campaigns and analytics for real-time strategy adjustments.

What is Criteo's current EPS?

Criteo has an EPS of 0.72, which is higher than the industry average.

Is Criteo's stock considered undervalued?

Indicators like a low P/E ratio of 7.45 and a P/S ratio of 0.63 suggest that Criteo's stock may be undervalued compared to industry norms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

GQG Partners Launches Innovative Active ETF for Investors

Updated Category News Views 183

GQG Partners Introduces First Active ETF GQG Partners, an emerging player in the financial services sector, is excited to announce its plans to launch the GQG US Equity ETF, marking its entry into the active ETF market. This innovative exchange-traded fund (ETF) will be available to U.S. investors in the upcoming summer season and is set to be listed under the ticker...

Continue Reading
Whimsocal Studios Unveils New Era for Joyful Brands

Updated Category News Views 230

Whimsocal Studios Launches as a New House of Happy Brands Whimsocal Studios has emerged as an exciting new parent company dedicated to creating joyful and functional brands that resonate with modern consumers. This innovative organization aims to enhance everyday life through thoughtful design and high-quality products. A Fusion of Celebratory Brands Whimsocal Studios...

Continue Reading
Bully Max Excels at American Advertising Awards with Triple Win

Updated Category News Views 475

Bully Max Shines at the Prestigious Advertising Awards Bully Max, renowned for its premium performance dog food, has made headlines by securing significant wins at the American Advertising Awards. The event took place at the enchanting Phipps Conservatory, where creativity and excellence were on full display. Crowning Achievement: Gold ADDY Award for Excellence The...

Continue Reading
Gen Z Entrepreneurs: The New Wave of Business Leaders Emerges

Updated Category News Views 182

Changing Times for Gen Z Entrepreneurs Climbing the corporate ladder can feel like a long journey, but think about this: what if the next person giving orders is a Gen Z dropout? With the rising cost of living and the diminishing appeal of traditional college education, many young individuals from this generation are increasingly turning to start their own ventures. The...

Continue Reading
Diversified Royalty Corp. Posts Record Q2 Results for 2025

Updated Category News Views 183

Record Performance from Diversified Royalty Corp. Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) has announced impressive financial results for the three months ended June 30, 2025, marking their strongest adjusted revenue quarter in company history. As a multi-royalty corporation, DIV is dedicated to acquiring top-line royalties from well-managed businesses and...

Continue Reading